The global nuclear medicine market is estimated to be USD 4,519.2 million in 2021 and is expected to witness a CAGR of 8.71% during the forecast period. Growing incidence of rare diseases, increasing alpha radioimmunotherapy-based targeted cancer treatment, and rising government initiatives to increase availability of mo-99 are the key drivers driving the global market growth. However, small half-life of radiopharmaceuticals, and hospital budget cuts coupled with high equipment prices are the factors hindering the market growth.
Global Nuclear Medicine Market Size (USD Million), 2021-2029
Source: Erevna Healthcare
By Type
Based on type, the market is segmented into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further divided into alpha emitters, beta emitters, and brachytherapy isotopes. Technological advancements and investment by government in nuclear medicine is driving the global market.
By Application
On the basis of application, the market is segmented into diagnostic and therapeutic applications market. In 2021, the diagnostic segment accounted for the largest market share in the global nuclear medicine market. The diagnostic segment is further segmented into thyroid applications, cardiology, bone scans, pulmonary scans, and others. The thyroid applications segment is anticipated to grow with the fastest CAGR during the forecast period. This is attributed to the increasing chronic disease cases and prevalence of thyroid disorders.
By Procedural Volume Assessment
Based on procedural volume assessment, the market is segmented into diagnostic and therapeutic procedures. In 2021, the diagnostic procedures accounted for the largest share in the global market. This attributed to the broad application of diagnostic radioisotopes as compared to therapeutic radioisotopes. This segment is anticipated to grow at a lucrative CAGR during the forecast period owing to increasing research and development activities.
Regional Insights
North America dominated the nuclear medicine global market in 2021 and is projected to maintain its domination during the forecast period. The reason for this market share is the increase in development of new technologies for radioisotope production, government funding, and company initiatives in the region that is expected to reinforce market growth in the future. The Asia Pacific is estimated to grow at the fastest growth rate during the forecast period increasing senior population and awareness about nuclear medicines & molecular imaging are contributing to the growth of the market in this region in this region
Competitor Insights
Some of the major companies in the market are Cardinal Health (U.S.), GE Healthcare (U.S.), Curium (France), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), JSC Isotope (Russia), and NorthStar Medical Radioisotopes (U.S.). Investment in R&D, strategic collaborations, mergers & acquisitions are some of the major strategies adopted by the leading players operating in the industry.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The nuclear medicine market report is categorized into the following segments and subsegments:
Nuclear Medicine Market, By Type (Revenue, 2021-2029, USD Million)
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- TC-99m
- I-123
- Tl-201
- GA-67
- Other SPECT Isotopes
- PET Radiopharmaceuticals
- F-18
- Rb-82
- Other PET Isotopes
- SPECT Radiopharmaceuticals
- Therapeutic Nuclear Medicine
- Alpha Emitters
- RA-223
- Beta Emitters
- Iodine-131
- Y-90
- SM-153
- LU-177
- RE-186
- Other Beta Emitters
- Brachytherapy Isotopes
- Iodine-125
- Iridium-192
- Palladium-103
- Cesium-131
- Other Brachytherapy Isotopes
- Alpha Emitters
Nuclear Medicine Market, By Application (Revenue, 2021-2029, USD Million)
- Diagnostic Applications
- SPECT Applications
- Cardiology
- Bone Scans
- Thyroid Applications
- Pulmonary Scans
- Other SPECT Applications
- PET Applications
- Oncology
- Cardiology
- Neurology
- Other PET Applications
- SPECT Applications
- Therapeutic Applications
- Thyroid Indications
- Bone Metastasis
- Endocrine Tumors
- Lymphoma
- Other Indications
Nuclear Medicine Market, By Procedural Volume Assessment (Revenue, 2021-2029, USD Million)
- Diagnostic Procedures
- SPECT Procedures
- PET Procedures
- Therapeutic Procedures
- Beta Emitter Procedures
- Alpha Emitter Procedures
- Brachytherapy Procedures
Nuclear Medicine Market, By Region (Revenue, 2021-2029, USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Scope of Nuclear Medicine Market Report:
Key Parameters | Details |
---|---|
Base Year |
|
Forecast Period |
|
Study Coverage |
|
Qualitative Analysis |
|
Regional Market Scope |
|
Company Profiles |
|
15% Free Customization Available |
|
Table of Contents: Nuclear Medicine Market 2021-2029
- Research Methodology
- Study Objectives
- Study Scope
- Research Assumptions
- Research Framework
- Research Models
- Bottom-up Approach
- Top-down Approach
- Data Triangulation
- Data Procurement
- Internal Database
- Secondary Research
- Purchased Database
- Primary Research
- Data Analysis
- Data Validation
- Market Size Estimation
- Market Forecast Model
- Quality Assessment
- Research Models
- Introduction: Nuclear Medicine
- Executive Summary
- Global Market Scenario
- Segment Market Scenario
- Geographic Market Scenario
- COVID-19 Impact
- Competitive Landscape
- Market Dynamics
- Market Drivers
- Driver 1
- Driver 2
- Driver 3
- Driver 4
- Driver 5
- Market Restraint
- Restraint 1
- Restraint 2
- Restraint 3
- Restraint 4
- Market Opportunities
- Opportunity 1
- Opportunity 2
- Opportunity 3
- Opportunity 4
- Market Trends
- Trend 1
- Trend 2
- Trend 3
- Trend 4
- Market Challenges
- Challenge 1
- Challenge 2
- Challenge 3
- Challenge 4
- Market Drivers
- Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- Value Chain Analysis
- SWOT Analysis
- Benchmark
- COVID-19 Impact Analysis: Nuclear Medicine Market
- COVID-19: Overview
- COVID-19 Impact on the Global Market
- COVID-19 Impact on the Regional Markets
- Market Analysis by Type
- Diagnostic Nuclear Medicine
- Diagnostic Nuclear Medicine Market Forecast, 2021-2029 (USD Million)
- Therapeutic Nuclear Medicine
- Therapeutic Nuclear Medicine Market Forecast, 2021-2029 (USD Million)
- Diagnostic Nuclear Medicine
- Market Analysis by Application
- Diagnostic Applications
- Diagnostic Applications Market Forecast, 2021-2029 (USD Million)
- Therapeutic Applications
- Therapeutic Applications Market Forecast, 2021-2029 (USD Million)
- Diagnostic Applications
- Market Analysis by Procedural Volume Assessment
- Diagnostic Procedures
- Diagnostic Procedures Market Forecast, 2021-2029 (USD Million)
- Therapeutic Procedures
- Therapeutic Procedures Market Forecast, 2021-2029 (USD Million)
- Diagnostic Procedures
- Regional Market Analysis
- Regional Market Trends
- Regional Market: Comparative Analysis
- North America Nuclear Medicine Market
- North America Nuclear Medicine Market
- North America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- S. Nuclear Medicine Market
- S. Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Canada Nuclear Medicine Market
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- S. Market Size and Forecast, 2021-2029 (USD Million)
- North America Market Size and Forecast, 2021-2029 (USD Million)
- North America Nuclear Medicine Market
- Europe Nuclear Medicine Market
- Europe Nuclear Medicine Market
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Germany Nuclear Medicine Market
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- UK Nuclear Medicine Market
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- France Nuclear Medicine Market
- France Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Spain Nuclear Medicine Market
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Italy Nuclear Medicine Market
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Europe Nuclear Medicine Market
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- France Market Size and Forecast, 2021-2029 (USD Million)
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Europe Nuclear Medicine Market
- Asia Pacific Nuclear Medicine Market
- Asia Pacific Nuclear Medicine Market
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Japan Nuclear Medicine Market
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- China Nuclear Medicine Market
- China Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- India Nuclear Medicine Market
- India Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- South Korea Nuclear Medicine Market
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Australia Nuclear Medicine Market
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Asia Pacific Nuclear Medicine Market
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- India Market Size and Forecast, 2021-2029 (USD Million)
- China Market Size and Forecast, 2021-2029 (USD Million)
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Nuclear Medicine Market
- Latin America Nuclear Medicine Market
- Latin America Nuclear Medicine Market
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Brazil Nuclear Medicine Market
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Mexico Nuclear Medicine Market
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Argentina Nuclear Medicine Market
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Latin America Nuclear Medicine Market
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Nuclear Medicine Market
- MEA Nuclear Medicine Market
- MEA Nuclear Medicine Market
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- GCC Nuclear Medicine Market
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- South Africa Nuclear Medicine Market
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of MEA Nuclear Medicine Market
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Type, 2021-2029 (USD Million)
- Market Size and Forecast by Application, 2021-2029 (USD Million)
- Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- MEA Nuclear Medicine Market
- Competitor Analysis
- Market Share Analysis, 2021 & 2029
- Competitive Mapping
- Key Players Market Place Analysis
- Major Recent Developments
- Company Profiles
- Cardinal Health (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- GE Healthcare (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Curium (France)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Lantheus Medical Imaging (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Bayer AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Bracco Imaging (Italy)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Eczacýbaþý-Monrol Nuclear Products (Turkey)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Nordion (Canada)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Advanced Accelerator Applications (France)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- Nanolive SA (Switzerland)
- Company Snapshot
- Company Overview
- Financials
- Application Benchmarking
- Recent Developments
- NTP Radioisotopes (South Africa)
- Company Snapshot
- Company Overview
- Financials
- Type Benchmarking
- Recent Developments
- JSC Isotope (Russia)
- Company Snapshot
- Company Overview
- Financials
- Type Benchmarking
- Recent Developments
- NorthStar Medical Radioisotopes (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Type Benchmarking
- Recent Developments
- Company 14
- Company Snapshot
- Company Overview
- Financials
- Type Benchmarking
- Recent Developments
- Company 15
- Company Snapshot
- Company Overview
- Financials
- Type Benchmarking
- Recent Developments
- Others Prominent Players
- Cardinal Health (U.S.)
Conclusion & Recommendations